This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Miles, W. M. Articles by Zipes, D. P. Search for Related Content PubMed PubMed Citation Articles by Miles, W. M. Articles by Zipes, D. P.

Circulation, Vol 74, 518-524, Copyright © 1986 by American Heart Association

ARTICLES

The implantable transvenous cardioverter: long-term efficacy and reproducible induction of ventricular tachycardia

WM Miles, EN Prystowsky, JJ Heger and DP Zipes

We followed 11 patients for 5 to 27 months (mean 14.9) after implantation of a permanent transvenous low-energy synchronized cardioverter to evaluate both long-term reproducibility of ventricular tachycardia (VT) induction via noninvasive programmed electrical stimulation with the cardioverter and efficacy of cardioversion. Induction and termination of VT were attempted at implantation and approximately every 3 months thereafter. All patients had coronary artery disease and were receiving antiarrhythmic drug therapy (amiodarone in eight). VT cycle length, morphology, and mode of induction were reproducible on multiple occasions in nine patients; clinical VT was induced inconsistently in two patients. Multiple VT episodes in five patients had one morphology, whereas two morphologies occurred in six patients. Synchronization of the shock within the QRS complex and right ventricular effective refractory periods determined via the cardioverter remained constant over the follow-up period. VT was terminated on every occasion in nine patients and on eight of nine occasions in one patient. Tachycardia was accelerated on three of five occasions in one patient. Consistently effective cardioversion energy (0.2 to 2.0 J) increased modestly in four patients. We conclude that patients with inducible monomorphic VT usually have sustained VT with similar characteristics inducible over a period of time and cardioversion and sensing functions of the cardioverter remain relatively stable over time.

This article has been cited by other articles:

				S. L. Pinski and G. J. Fahy The Proarrhythmic Potential of Implantable Cardioverter-Defibrillators Circulation, September 15, 1995; 92(6): 1651 - 1664. [Abstract] [Full Text]

				A. M. Gillis, R. S. Sheldon, D. G. Wyse, J. W. Leitch, R. Yee, G. J. Klein, H. J. Duff, and L. B. Mitchell Long-term Reproducibility of Ventricular Tachycardia Induction in Patients With Implantable Cardioverter/Defibrillators : Serial Noninvasive Studies Circulation, May 15, 1995; 91(10): 2605 - 2613. [Abstract] [Full Text]

				A. S. Manolis Transvenous Endocardial Cardioverter Defibrillator Systems: Is the Future Here? Arch Intern Med, March 28, 1994; 154(6): 617 - 622. [Abstract] [PDF]

				J. Borbola, P. Denes, M. D. Ezri, R. G. Hauser, C. Serry, and M. D. Goldin The Automatic Implantable Cardioverter-Defibrillator: Clinical Experience, Complications, and Follow-up in 25 Patients Arch Intern Med, January 1, 1988; 148(1): 70 - 76. [Abstract] [PDF]